对肺癌分子向治疗和免疫治疗的机制性见解
Teresa Vincent1, Kunnathur Murugesan Sakthivel2, C M Reena Josephine3
1Apex Research and Scientific Writing Academy, NC, 27707, United States of America.
Biochemical and biophysical research communications
|June 24, 2025
概括
向疗法和免疫疗法通过抑制癌细胞生长和增强免疫反应,提供精确的肺癌治疗. 将这些先进疗法结合起来,有望改善患者的治疗结果,克服治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 癌症治疗方法 癌症治疗方法
- 免疫学 免疫学 免疫学
背景情况:
- 肺癌仍然是一个重要的全球健康问题,在化学疗法和放射治疗等常规治疗中有效性和特异性有限.
- 向治疗和免疫治疗代表着有前途的进展,提供选择性向癌细胞和增强免疫反应.
- 肺癌的特定分子标包括EGFR,KRAS,BRAF以及MAPK,PI3K和MYC等途径,这些途径对细胞增殖和生存至关重要.
研究的目的:
- 审查针对性治疗和免疫治疗在肺癌治疗中的进展和潜力.
- 突出针对性治疗和免疫疗法的作用机制,以对抗肺癌.
- 强调涉及这些新治疗方法的组合策略的重要性.
主要方法:
- 针对肺癌的向治疗和免疫治疗的当前文献的综述.
- 分析分子点和涉及肺癌进展的途径.
- 检查免疫细胞功能和免疫检查点在消除癌症.
主要成果:
- 向疗法有效地抑制特定的分子标 (例如EGFR,KRAS,BRAF) 和路径 (MAPK,PI3K,MYC),这些路径对肺癌生长至关重要.
- 免疫疗法利用NK细胞和T细胞等免疫细胞,并调节免疫检查点以消除癌细胞.
- 这两种方法都显示出与传统治疗相比,提高疗效和特异性的潜力.
结论:
- 分子向疗法和免疫疗法改变了肺癌的治疗方法,提供了精确性和克服耐药性.
- 针对性治疗和免疫治疗在组合策略中的整合对改善临床结果具有显著的前景.
- 未来的研究和临床应用应专注于优化这些组合方法,以改善肺癌管理.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.1K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:27Cytotoxic T Cells-mediated Immune Response
2.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.5K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K